Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Repotrectinib for treating advanced or metastatic nonsmall-cell lung cancer with ROS1-postive mutation	Repotrectinib (TPX 0005)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Resmetirom for non-alcoholic steatohepatitis	Resmetirom (MGL-3196)	Non-alcoholic steatohepatitis (NASH)	Hepatology	2023	View \| Download
Rilzabrutinib for treating persistent or chronic immune thrombocytopenia	Rilzabrutinib	Immune thrombocytopenia (ITP)	Haematology , Immunology	2023	View \| Download
Ruxolitinib for grades II-IV treatment-naïve or steroid-refractory acute graft versus host disease	Ruxolitinib (Jakavi; INCB018424; CTP-543; ruxolitinib phosphate)	Graft versus host disease (GvHD)	Immunology	2023	View \| Download
Ruxolitinib for treating chronic graft versus host disease after allogeneic stem cell transplant in paediatric patients	Ruxolitinib (Jakavi; INCB018424; CTP-543; ruxolitinib phosphate)	Graft versus host disease (GvHD)	Immunology	2023	View \| Download
Sacituzumab govitecan for previously treated advanced non-small cell lung cancer	Sacituzumab Govitecan (IMMU-132; Trodelvy)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Sacituzumab govitecan for treating previously untreated locally advanced or metastatic triple negative breast cancer with negative PD-L1 status	Sacituzumab Govitecan (IMMU-132; Trodelvy)	Breast cancer	Breast Cancer	2023	View \| Download
SAR443820 for treating amyotrophic lateral sclerosis (ALS)	SAR443820 (DNL788)	Amyotrophic lateral sclerosis	Neurology	2023	View \| Download
Sarilumab for treating Polyarticular-course Juvenile idiopathic arthritis in children and adolescents	Sarilumab	Juvenile idiopathic arthritis	Rheumatology	2023	View \| Download
Sebetralstat for treating hereditary angioedema	Sebetralstat (KVD-900)	Hereditary angioedema (HAE)	Genetic Disorders , Immunology	2023	View \| Download